COMP <GO>
AORT vs IRMD // 10Y YIELD & FRED MACRO BETA
Artivion Inc. (NYSE) VS. iRadimed Corporation (NASDAQ) • 15-METRIC TALLY: AORT 4
— IRMD 8
■ METRIC PARITY
LAST: $22.58 (-3.67%) • MKT CAP: $1.14B
macro-sensitivity
—
LAST: $76.68 (-10.57%) • MKT CAP: $1.10B
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AORT VS. IRMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AORT | IRMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.40% | 76.70% | -12.30 | IRMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.50% | 37.70% | -33.20 | IRMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.3x | 31.9x | -12.60 | AORT | /valuation <GO> |
| Free Cash Flow Yield | 0.07% | 1.57% | -1.50 | IRMD | /fcf-yield <GO> |
| Operating Margin | 7.60% | 31.20% | -23.60 | IRMD | /operating-margins <GO> |
| Net Profit Margin | 2.20% | 26.80% | -24.60 | IRMD | /net-margins <GO> |
| Revenue Growth (YoY) | 13.60% | 14.40% | -0.80 | IRMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.37% | -1.37 | IRMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.46 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | AORT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.6 | 50.1 | +3.50 | AORT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 98.3x | 41.0x | +57.30 | IRMD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.14B | $1.10B | $46.5M | AORT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AORT REV | IRMD REV | AORT GROSS % | IRMD GROSS % | AORT FCF | IRMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $441.3M | $83.8M | 64.4% | 76.7% | $839.0K | $17.2M |
| FY 2024 | $388.5M | $73.2M | 64.0% | 76.9% | $11.0M | $17.6M |
| FY 2023 | $354.0M | $65.6M | — | — | $18.8M | $13.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AORT // BETA —
IRMD // BETA —